The adhesion molecules EpCAM, α2β1 and CD44 s were seen to mediate tumour cell adhesion to the peritoneum and might be particularly useful in the prevention of minimal residual disease in high-risk patients, such as patients with T4 colon tumours [21, 22]. The gene discussed is EPCAM; the disease is neoplasm.